On CNBC's "Mad Money Lightning Round," Jim Cramer said that NeoGenomics, Inc. NEO is a good spec, because early diagnostic of cancer is a holy grail.
Cramer is not a buyer of Yeti Holdings Inc YETI because it's already up 100% for the year.
Nutanix Inc NTNX is making a little comeback, but Cramer finds it too hard to recommend the stock.
Cadence Design Systems Inc CDNS is overvalued, said Cramer. He added that the company has never been able to put together a systematic year of great numbers. He is not a buyer.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in